Home � News From UNITED STATES � News From Healthcare and Medical
Fda grants accelerated approval to gileads hepcludex(r) (bulevirtide-gmod), the first and only approved treatment for chronic hepatitis delta virus (hdv) in UNITED STATES
| TI Ref No: | 533228971 |
| Date : | 24 May 2026 |
| Description: | Fda grants accelerated approval to gileads hepcludex(r) (bulevirtide-gmod), the first and only approved treatment for chronic hepatitis delta virus (hdv), UNITED STATES |
| Document Type | Procurement News |
|
Click Here For Login If you are registered member, kindly login to view full details of this tender notice. |
|
|
Subscribe Now If you are not a subscriber, kindly contact nikhil.j@tendersinfo.com OR Naorm@export.gov.il |